{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:09:15Z","timestamp":1767024555286,"version":"3.48.0"},"posted":{"date-parts":[[2025,4,28]]},"group-title":"In Review","reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,31]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n  Contingency management (CM) is an effective yet underutilized behavioral intervention that uses rewards to improve outcomes in medication for opioid use disorder (MOUD) treatment. Prior implementation attempts have focused on specialized addiction clinics, using intensive daily treatment with methadone and high reward values (e.g. &gt;$200 total). However, many people get MOUD from less specialized, more accessible, family medicine clinics. These clinics could also benefit from CM, yet present unique challenges for CM. Family medicine clinics typically use buprenorphine as their primary medication, which requires less intensive dosing schedules and thus provides fewer CM opportunities. They may also have lower institutional willingness to use high-value rewards. As an initial step in user-centered design of a low value reward (&lt;$75 total) CM program for the family medicine context, we conducted qualitative interviews with patients and staff in the buprenorphine treatment program of a family medicine department. We gathered and analyzed qualitative data on CM knowledge, preferred program parameters, and implementation considerations.\nMethod\n Participants (\n                  <italic>N<\/italic>\n                  \u2009=\u200924) were buprenorphine treatment staff (\n                  <italic>n<\/italic>\n                  \u2009=\u200912) and patients (\n                  <italic>n<\/italic>\n                  \u2009=\u200912). Participants completed 30\u201350-minute semi-structured interviews, analyzed using rapid matrix analysis.\nResults\n Participants had little experience with CM, but generally viewed CM as acceptable, appropriate, and feasible. Interviewees coalesced around having staff who were not providers with prescription privileges conduct CM, consistent rather than escalating payments, and physical rewards delivered in-person. Potential challenges included medical record integration, demands on staff time, and confirmation of patients\u2019 goal completion.\nConclusions\n Patient and staff feedback was well-aligned, especially regarding rewards as an opportunity for staff-patient connection and the need for simplicity. Some consensus suggestions (e.g. non-escalating rewards) conflict with extant CM literature. Implications for implementation of CM in this setting are presented. These findings inform user-centered design and iteration of a CM program for this accessible, non-specialized family medicine setting.\n                <\/p>","DOI":"10.21203\/rs.3.rs-6347618\/v1","type":"posted-content","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:02:42Z","timestamp":1745838162000},"source":"Crossref","is-referenced-by-count":0,"title":["Implementing contingency management in family medicine: A qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment"],"prefix":"10.21203","author":[{"given":"Samantha","family":"Ellis","sequence":"first","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jax","family":"Witzig","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Basaldu","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Rudd","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Gastala","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra R.","family":"Tabachnick","sequence":"additional","affiliation":[{"name":"Northwestern University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Kang","sequence":"additional","affiliation":[{"name":"Loyola University Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tondalaya","family":"Henry","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Stackhouse","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Wardle","sequence":"additional","affiliation":[{"name":"University of Illinois at Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","article-title":"Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA","volume":"17","author":"Abraham AJ","year":"2020","unstructured":"Abraham AJ, Andrews CM, Harris SJ, Friedmann PD. Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA. Neurotherapeutics. 2020;17(1):55\u201369. https:\/\/doi.org\/10.1007\/s13311-019-00814-4.","journal-title":"Neurotherapeutics"},{"year":"2022","author":"Amura CR","key":"ref2","unstructured":"Amura CR. (2022). Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado."},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/104973230201200611","article-title":"Matrix Analysis as a Complementary Analytic Strategy in Qualitative Inquiry","volume":"12","author":"Averill JB","year":"2002","unstructured":"Averill JB. Matrix Analysis as a Complementary Analytic Strategy in Qualitative Inquiry. Qual Health Res. 2002;12(6):855\u201366. https:\/\/doi.org\/10.1177\/104973230201200611.","journal-title":"Qual Health Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"107594","DOI":"10.1016\/j.ypmed.2023.107594","article-title":"Effective, but underused: Lessons learned implementing contingency management in real-world practice settings in the United States","volume":"176","author":"Becker SJ","year":"2023","unstructured":"Becker SJ, DiClemente-Bosco K, Rash CJ, Garner BR. Effective, but underused: Lessons learned implementing contingency management in real-world practice settings in the United States. Prev Med. 2023;176:107594\u2013107594. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107594.","journal-title":"Prev Med"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-023-01297-w","article-title":"Implementing contingency management for stimulant use in opioid treatment programs: Protocol of a type III hybrid effectiveness-stepped-wedge trial","volume":"18","author":"Becker SJ","year":"2023","unstructured":"Becker SJ, DiClemente-Bosco K, Scott K, Janssen T, Salino SM, Hasan FN, Yap KR, Garner BR. Implementing contingency management for stimulant use in opioid treatment programs: Protocol of a type III hybrid effectiveness-stepped-wedge trial. Implement Sci : IS. 2023;18(1):41\u201341. https:\/\/doi.org\/10.1186\/s13012-023-01297-w.","journal-title":"Implement Sci : IS"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13722-021-00268-0","article-title":"Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial","volume":"16","author":"Becker SJ","year":"2021","unstructured":"Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden LM, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial. Addict Sci Clin Pract. 2021;16(1):61. https:\/\/doi.org\/10.1186\/s13722-021-00268-0.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12913-019-4308-6","article-title":"User-centered design of contingency management for implementation in opioid treatment programs: A qualitative study","volume":"19","author":"Becker SJ","year":"2019","unstructured":"Becker SJ, Scott K, Murphy CM, Pielech M, Moul SA, Yap KR, Garner BR. User-centered design of contingency management for implementation in opioid treatment programs: A qualitative study. BMC Health Serv Res. 2019a;19(1):466. https:\/\/doi.org\/10.1186\/s12913-019-4308-6.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12913-019-4308-6","article-title":"User-centered design of contingency management for implementation in opioid treatment programs: A qualitative study","volume":"19","author":"Becker SJ","year":"2019","unstructured":"Becker SJ, Scott K, Murphy CM, Pielech M, Moul SA, Yap KR, Garner BR. User-centered design of contingency management for implementation in opioid treatment programs: A qualitative study. BMC Health Serv Res. 2019b;19(1):466. https:\/\/doi.org\/10.1186\/s12913-019-4308-6.","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"ref9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","volume":"104","author":"Bell J","year":"2009","unstructured":"Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104(7):1193\u2013200. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02627.x.","journal-title":"Addiction"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1969","article-title":"Contingency Management for Patients Receiving Medication for Opioid Use Disorder","author":"Bol\u00edvar HA","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency Management for Patients Receiving Medication for Opioid Use Disorder. JAMA Psychiatry. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1969.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12501","article-title":"Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice","volume":"1327","author":"Carroll KM","year":"2014","unstructured":"Carroll KM. Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice. Ann N Y Acad Sci. 2014;1327(1). https:\/\/doi.org\/10.1111\/nyas.12501. n\/a-n\/a.","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"107726","DOI":"10.1016\/j.ypmed.2023.107726","article-title":"Federal legal and regulatory aspects of contingency management incentives","volume":"176","author":"Clark HW","year":"2023","unstructured":"Clark HW, Davis M. Federal legal and regulatory aspects of contingency management incentives. Prev Med. 2023;176:107726. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107726.","journal-title":"Prev Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2012.04.017","author":"DeFulio A","year":"2012","unstructured":"DeFulio A, Silverman K. (2012). The use of incentives to reinforce medication adherence. Preventive Medicine, 55(SUPPL.), S86\u2013S94. https:\/\/doi.org\/10.1016\/j.ypmed.2012.04.017"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","article-title":"Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies","volume":"10","author":"Degenhardt L","year":"2023","unstructured":"Degenhardt L, Clark B, Macpherson G, Leppan O, Nielsen S, Zahra E, Larance B, Kimber J, Martino-Burke D, Hickman M, Farrell M. Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 2023;10(6):386\u2013402. https:\/\/doi.org\/10.1016\/S2215-0366(23)00095-0.","journal-title":"Lancet Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.drugalcdep.2017.12.020","article-title":"The national implementation of Contingency Management (CM) in the Department of Veterans Affairs: Attendance at CM sessions and substance use outcomes","volume":"185","author":"DePhilippis D","year":"2018","unstructured":"DePhilippis D, Petry NM, Bonn-Miller MO, Rosenbach SB, McKay JR. The national implementation of Contingency Management (CM) in the Department of Veterans Affairs: Attendance at CM sessions and substance use outcomes. Drug Alcohol Depend. 2018;185:367\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.020.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction","volume":"10","author":"Dugosh K","year":"2016","unstructured":"Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction. J Addict Med. 2016;10(2):93. https:\/\/doi.org\/10.1097\/ADM.0000000000000193.","journal-title":"J Addict Med"},{"year":"2019","author":"Gale RC","key":"ref17","unstructured":"Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder L, Midboe A. (2019). Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration\u2014University of Illinois at Chicago Library. https:\/\/i-share-uic.primo.exlibrisgroup.com\/discovery\/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_c0f2c1513d1c4ccc83799eeda89237b9&context=PC&vid=01CARLI_UIC:CARLI_UIC\u27e8=en&search_scope=MyInst_and_CI&adaptor=Primo%20Central&tab=LibraryCatalogPlus&query=any,contains,Gale,%20R.C.,%20Wu,%20J.,%20Erhardt,%20T.,%20Bounthavong,%20M.,%20Reardon,%20C.,%20Damschroder,%20L.,%20%26%20Midboe,%20A.%20(2019).%20%20Comparison%20of%20rapid%20vs.%20in-depth%20qualitative%20analytic%20methods%20from%20a%20process%20evaluation%20of%20academic%20detailing%20in%20the%20Veterans%20Health%20Administration.%20Implementation%20Science,%2014(11),%20pages%20unavailable.%20https:%2F%2Fdoi.org%2F10.1186%2Fs13012-019-0853-y&offset=0."},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.10.007","article-title":"Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study","volume":"30","author":"Gerra G","year":"2006","unstructured":"Gerra G, C, L., A, D., G, S., R, F., C, A., A, Z.,A, L. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress Neuro-Psychopharmacology Biological Psychiatry. 2006;30(2). https:\/\/doi.org\/10.1016\/j.pnpbp.2005.10.007.","journal-title":"Progress Neuro-Psychopharmacology Biological Psychiatry"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1037\/ccp0000552","article-title":"Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis","volume":"89","author":"Ginley MK","year":"2021","unstructured":"Ginley MK, Pfund RA, Rash CJ, Zajac K. Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis. J Consult Clin Psychol. 2021;89(1):58\u201371. https:\/\/doi.org\/10.1037\/ccp0000552.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0376-8716(99)00068-X","article-title":"Contingency management in outpatient methadone treatment: A meta-analysis","volume":"58","author":"Griffith JD","year":"2000","unstructured":"Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: A meta-analysis. Drug Alcohol Depend. 2000;58(1):55\u201366. https:\/\/doi.org\/10.1016\/S0376-8716(99)00068-X.","journal-title":"Drug Alcohol Depend"},{"year":"2013","author":"Hamilton A","key":"ref21","unstructured":"Hamilton A. (2013). Qualitative Methods in Rapid Turn-Around Health Services Research. https:\/\/www.hsrd.research.va.gov\/for_researchers\/cyber_seminars\/archives\/video_archive.cfm?SessionID=780"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/19359705.2021.1995096","article-title":"Latino sexual minority men\u2019s intersectional minority stress, general stress, and coping during COVID-19: A rapid qualitative study","volume":"26","author":"Harkness A","year":"2022","unstructured":"Harkness A, Weinstein ER, Atuluru P, Hernandez Altamirano D, Vidal R, Rodriguez-Diaz CE, Safren SA. Latino sexual minority men\u2019s intersectional minority stress, general stress, and coping during COVID-19: A rapid qualitative study. Journal Gay Lesbian Mental Health. 2022;26(2):130\u201357. https:\/\/doi.org\/10.1080\/19359705.2021.1995096.","journal-title":"Journal Gay Lesbian Mental Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"208941","DOI":"10.1016\/j.josat.2022.208941","article-title":"Community implementation of contingency management to address stimulant use","volume":"151","author":"Hartzler B","year":"2023","unstructured":"Hartzler B, Gray K, Marx M, Kirk-Lewis K, Payne-Smith K, McIlveen JW. Community implementation of contingency management to address stimulant use. J Subst Use Addict Treat. 2023;151:208941. https:\/\/doi.org\/10.1016\/j.josat.2022.208941.","journal-title":"J Subst Use Addict Treat"},{"issue":"4","key":"ref26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jsat.2013.12.007","article-title":"Disseminating contingency management: Impacts of staff training and implementation at an opiate treatment program","volume":"46","author":"Hartzler B","year":"2014","unstructured":"Hartzler B, Jackson TR, Jones BE, Beadnell B, Calsyn DA. Disseminating contingency management: Impacts of staff training and implementation at an opiate treatment program. J Subst Abuse Treat. 2014;46(4):429\u201338. https:\/\/doi.org\/10.1016\/j.jsat.2013.12.007.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"ref27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jsat.2013.01.014","article-title":"Community opioid treatment perspectives on contingency management: Perceived feasibility, effectiveness, and transportability of social and financial incentives","volume":"45","author":"Hartzler B","year":"2013","unstructured":"Hartzler B, Rabun C. Community opioid treatment perspectives on contingency management: Perceived feasibility, effectiveness, and transportability of social and financial incentives. J Subst Abuse Treat. 2013;45(2):242\u20138. https:\/\/doi.org\/10.1016\/j.jsat.2013.01.014.","journal-title":"J Subst Abuse Treat"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2018.09.004","article-title":"Training community-based treatment providers to implement contingency management for opioid addiction: Time to and frequency of adoption","volume":"95","author":"Helseth SA","year":"2018","unstructured":"Helseth SA, Janssen T, Scott K, Squires DD, Becker SJ. Training community-based treatment providers to implement contingency management for opioid addiction: Time to and frequency of adoption. J Subst Abuse Treat. 2018;95:26\u201334. https:\/\/doi.org\/10.1016\/j.jsat.2018.09.004.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2006.03.010","article-title":"Substance abuse treatment providers\u2019 beliefs and objections regarding contingency management: Implications for dissemination","volume":"85","author":"Kirby KC","year":"2006","unstructured":"Kirby KC, Benishek LA, Dugosh KL, Kerwin ME. Substance abuse treatment providers\u2019 beliefs and objections regarding contingency management: Implications for dissemination. Drug Alcohol Depend. 2006;85(1):19\u201327. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.03.010.","journal-title":"Drug Alcohol Depend"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jsat.2016.06.012","article-title":"The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a Real-World Application of Contingency Management","volume":"72","author":"Kropp F","year":"2017","unstructured":"Kropp F, Lewis D, Winhusen T. The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a Real-World Application of Contingency Management. J Subst Abuse Treat. 2017;72:111\u20136. https:\/\/doi.org\/10.1016\/j.jsat.2016.06.012.","journal-title":"J Subst Abuse Treat"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsat.2015.01.009","article-title":"Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment","volume":"54","author":"Levine AR","year":"2015","unstructured":"Levine AR, Lundahl LH, Ledgerwood DM, Lisieski M, Rhodes GL, Greenwald MK. Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment. J Subst Abuse Treat. 2015;54:37\u201343. https:\/\/doi.org\/10.1016\/j.jsat.2015.01.009.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"ref32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.01.016","article-title":"Contingency management treatments that reinforce completion of goal-related activities: Participation in family activities and its association with outcomes","volume":"79","author":"Lewis MW","year":"2005","unstructured":"Lewis MW, Petry NM. Contingency management treatments that reinforce completion of goal-related activities: Participation in family activities and its association with outcomes. Drug Alcohol Depend. 2005;79(2):267\u201371. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.01.016.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","article-title":"A meta-analysis of voucher-based reinforcement therapy for substance use disorders","volume":"101","author":"Lussier JP","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192\u2013203. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01311.x.","journal-title":"Addiction"},{"issue":"2","key":"ref34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/cpsp.12154","article-title":"User-centered design for psychosocial intervention development and implementation","volume":"23","author":"Lyon AR","year":"2016","unstructured":"Lyon AR, Koerner K. User-centered design for psychosocial intervention development and implementation. Clin Psychol Sci Pract. 2016;23(2):180\u2013200. https:\/\/doi.org\/10.1111\/cpsp.12154.","journal-title":"Clin Psychol Sci Pract"},{"year":"2024","author":"Marcovitz DE","key":"ref35","unstructured":"Marcovitz DE. (n.d.). Predictors of early dropout in outpatient buprenorphine\/naloxone treatment\u2014PubMed. Retrieved May 22, 2024, from https:\/\/pubmed.ncbi.nlm.nih.gov\/27442456\/"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4","author":"Mattson CL","year":"2021","unstructured":"Mattson CL. (2021). Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths\u2014United States, 2013\u20132019. MMWR. Morbidity and Mortality Weekly Report, 70. https:\/\/doi.org\/10.15585\/mmwr.mm7006a4"},{"issue":"4","key":"ref37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jsat.2004.03.003","article-title":"A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system","volume":"26","author":"McGovern MP","year":"2004","unstructured":"McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J Subst Abuse Treat. 2004a;26(4):305\u201312. https:\/\/doi.org\/10.1016\/j.jsat.2004.03.003.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"ref38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jsat.2004.03.003","article-title":"A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system","volume":"26","author":"McGovern MP","year":"2004","unstructured":"McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J Subst Abuse Treat. 2004b;26(4):305\u201312. https:\/\/doi.org\/10.1016\/j.jsat.2004.03.003.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"ref39","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.focus.2023.100177","article-title":"Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19","volume":"3","author":"Meyerson BE","year":"2024","unstructured":"Meyerson BE, Bentele KG, Brady BR, Stavros N, Russell DM, Mahoney AN, Garnett I, Jackson S, Garcia RC, Coles HB, Granillo B, Carter GA. Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19. AJPM Focus. 2024;3(2):100177. https:\/\/doi.org\/10.1016\/j.focus.2023.100177.","journal-title":"AJPM Focus"},{"year":"2021","author":"Nevedal A","key":"ref40","unstructured":"Nevedal A, Reardon CM, Winderquist MA, Jackson GL, Cutrona SL, White BS, Damschroder LJ. (2021). Rapid versus traditional qualitative analysis using the Consolidated Framework for Implementation Research (CFIR)\u2014University of Illinois at Chicago Library. https:\/\/i-share-uic.primo.exlibrisgroup.com\/discovery\/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_2a8ee3039ac44544a60330d86ffdf393&context=PC&vid=01CARLI_UIC:CARLI_UIC\u27e8=en&search_scope=MyInst_and_CI&adaptor=Primo%20Central&tab=LibraryCatalogPlus&query=any,contains,Nevedal,%20A.%20L.,%20Reardon,%20C.%20M.,%20Widerquist,%20M.%20A.,%20Jackson,%20G.%20L.,%20Cutrona,%20S.%20L.,%20White,%20B.%20S.,%20%26%20Damschroder,%20L.%20J.%20(2021).%20Rapid%20versus%20traditional%20qualitative%20analysis%20using%20the%20Consolidated%20Framework%20for%20Implementation%20Research%20(CFIR).%20Implementation%20Science,%2016(1).&offset=0"},{"year":"2018","author":"Nicholas E","key":"ref41","unstructured":"Nicholas E, Hagemeier P. (2018). Introduction to the Opioid Epidemic: The Economic Burden on the Healthcare System and Impact on Quality of Life. 24. https:\/\/www.ajmc.com\/view\/intro-opioid-epidemic-economic-burden-on-healthcare-system-impact-quality-of-life"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/JAN.0000000000000320","article-title":"Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients","volume":"31","author":"Noe SR","year":"2020","unstructured":"Noe SR, Keller T. Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients. J Addictions Nurs. 2020;31(1):23\u20139. https:\/\/doi.org\/10.1097\/JAN.0000000000000320.","journal-title":"J Addictions Nurs"},{"issue":"6","key":"ref43","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1377\/hlthaff.2019.01622","article-title":"Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others","volume":"39","author":"Olfson M","year":"2020","unstructured":"Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others. Health Aff. 2020;39(6):984\u201392. https:\/\/doi.org\/10.1377\/hlthaff.2019.01622.","journal-title":"Health Aff"},{"year":"2023","author":"Oluwoye O","key":"ref44","unstructured":"Oluwoye O, Weeks DL, McDonell MG. (2023). An unexplored equity factor: Differential beliefs and attitudes toward contingency management by providers\u2019 ethnicity."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"107614","DOI":"10.1016\/j.ypmed.2023.107614","article-title":"Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States","volume":"176","author":"Parent SC","year":"2023","unstructured":"Parent SC, Peavy KM, Tyutyunnyk D, Hirchak KA, Nauts T, Dura A, Weed L, Barker L, McDonell MG. Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States. Prev Med. 2023;176:107614. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107614.","journal-title":"Prev Med"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(99)00071-X","article-title":"A comprehensive guide to the application of contingency management procedures in clinical settings","volume":"58","author":"Petry NM","year":"2000","unstructured":"Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000;58(1):9\u201325.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"ref47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1037\/a0026826","article-title":"A randomized trial of contingency management delivered by community therapists","volume":"80","author":"Petry NM","year":"2012","unstructured":"Petry NM, Alessi SM, Ledgerwood DM. A randomized trial of contingency management delivered by community therapists. J Consult Clin Psychol. 2012a;80(2):286\u201398. https:\/\/doi.org\/10.1037\/a0026826.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2011.09.015","article-title":"Contingency management delivered by community therapists in outpatient settings","volume":"122","author":"Petry NM","year":"2012","unstructured":"Petry NM, Alessi SM, Ledgerwood DM. Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend. 2012b;122(1):86\u201392. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.09.015.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"ref49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1037\/ccp0000330","article-title":"A randomized trial of contingency management reinforcing attendance at treatment: Do duration and timing of reinforcement matter","volume":"86","author":"Petry NM","year":"2018","unstructured":"Petry NM, Alessi SM, Rash CJ, Barry D, Carroll KM. A randomized trial of contingency management reinforcing attendance at treatment: Do duration and timing of reinforcement matter. J Consult Clin Psychol. 2018;86(10):799\u2013809. https:\/\/doi.org\/10.1037\/ccp0000330.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"ref50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.drugalcdep.2005.11.023","article-title":"Prize-based contingency management does not increase gambling","volume":"83","author":"Petry NM","year":"2006","unstructured":"Petry NM, Kolodner KB, Li R, Peirce JM, Roll JM, Stitzer ML, Hamilton JA. Prize-based contingency management does not increase gambling. Drug Alcohol Depend. 2006;83(3):269\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.11.023.","journal-title":"Drug Alcohol Depend"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"108556","DOI":"10.1016\/j.jsat.2021.108556","article-title":"Contingency management for treatment attendance: A meta-analysis","author":"Pfund RA","year":"2021","unstructured":"Pfund RA, Ginley MK, Rash CJ, Zajac K. Contingency management for treatment attendance: A meta-analysis. J Subst Abuse Treat. 2021;108556. https:\/\/doi.org\/10.1016\/j.jsat.2021.108556.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"ref52","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: A meta-analysis","volume":"101","author":"Prendergast M","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction. 2006;101(11):1546\u201360. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01581.x.","journal-title":"Addiction"},{"issue":"1","key":"ref53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1037\/adb0000496","article-title":"Examining Implementation of Contingency Management in Real-World Settings","volume":"34","author":"Rash CJ","year":"2019","unstructured":"Rash CJ, Alessi SM, Zajac K. Examining Implementation of Contingency Management in Real-World Settings. Psychol Addict Behav. 2019;34(1):89. https:\/\/doi.org\/10.1037\/adb0000496.","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"ref54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2011.08.027","article-title":"Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire","volume":"121","author":"Rash CJ","year":"2012","unstructured":"Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 2012;121(3):205\u201312. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.08.027.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"ref55","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.sapharm.2021.05.013","article-title":"Use of Rapid Assessment Procedures when analyzing qualitative data in pharmacy research","volume":"18","author":"Renfro CP","year":"2022","unstructured":"Renfro CP, Rome Z, Gatwood J, Hohmeier KC. Use of Rapid Assessment Procedures when analyzing qualitative data in pharmacy research. Res Social Administrative Pharm. 2022;18(1):2249\u201353. https:\/\/doi.org\/10.1016\/j.sapharm.2021.05.013.","journal-title":"Res Social Administrative Pharm"},{"issue":"9","key":"ref56","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"Roll JM","year":"2013","unstructured":"Roll JM, Chudzynski J, Cameron JM, Howell DN, McPherson S. Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav. 2013;38(9):2455\u201362. https:\/\/doi.org\/10.1016\/j.addbeh.2013.03.018.","journal-title":"Addict Behav"},{"issue":"1","key":"ref57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/BF03391732","article-title":"Facilitating the Adoption of Contingency Management for the Treatment of Substance Use Disorders","volume":"2","author":"Roll JM","year":"2009","unstructured":"Roll JM, Madden GJ, Rawson R, Petry NM. Facilitating the Adoption of Contingency Management for the Treatment of Substance Use Disorders. Behav Anal Pract. 2009;2(1):4\u201313. https:\/\/doi.org\/10.1007\/BF03391732.","journal-title":"Behav Anal Pract"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples H","year":"2018","unstructured":"Samples H, Williams AR, Olfson M, Crystal S. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abuse Treat. 2018;95:9\u201317. https:\/\/doi.org\/10.1016\/j.jsat.2018.09.001.","journal-title":"J Subst Abuse Treat"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1037\/tps0000245","article-title":"Health professional stigma as a barrier to contingency management implementation in opioid treatment programs","author":"Scott K","year":"2020","unstructured":"Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Translational Issues Psychol Sci. 2020. https:\/\/doi.org\/10.1037\/tps0000245.","journal-title":"Translational Issues Psychol Sci"},{"issue":"10","key":"ref60","doi-asserted-by":"publisher","first-page":"e019993","DOI":"10.1136\/bmjopen-2017-019993","article-title":"Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis","volume":"8","author":"Taylor B","year":"2018","unstructured":"Taylor B, Henshall C, Kenyon S, Litchfield I, Greenfield S. Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open. 2018;8(10):e019993\u2013019993. https:\/\/doi.org\/10.1136\/bmjopen-2017-019993.","journal-title":"BMJ Open"},{"issue":"1","key":"ref61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko C","year":"2016","unstructured":"Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: A systematic review. J Addict Dis. 2016;35(1):22\u201335. https:\/\/doi.org\/10.1080\/10550887.2016.1100960.","journal-title":"J Addict Dis"},{"issue":"11","key":"ref62","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1176\/appi.ps.202000250","article-title":"Suddenly Becoming a Virtual Doctor: Experiences of Psychiatrists Transitioning to Telemedicine During the COVID-19 Pandemic","volume":"71","author":"Uscher-Pines L","year":"2020","unstructured":"Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett ML, Huskamp HA. Suddenly Becoming a Virtual Doctor: Experiences of Psychiatrists Transitioning to Telemedicine During the COVID-19 Pandemic. Psychiatric Serv (Washington D C). 2020;71(11):1143\u201350. https:\/\/doi.org\/10.1176\/appi.ps.202000250.","journal-title":"Psychiatric Serv (Washington D C)"},{"issue":"2","key":"ref63","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder","volume":"3","author":"Wakeman SE","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020;3(2):e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"ref64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/a0023617","article-title":"Delay Discounting is Associated with Treatment Response among Cocaine-Dependent Outpatients","volume":"19","author":"Washio Y","year":"2011","unstructured":"Washio Y, Higgins ST, Heil SH, McKerchar TL, Badger GJ, Skelly JM, Dantona RL. Delay Discounting is Associated with Treatment Response among Cocaine-Dependent Outpatients. Exp Clin Psychopharmacol. 2011;19(3):243\u20138. https:\/\/doi.org\/10.1037\/a0023617.","journal-title":"Exp Clin Psychopharmacol"},{"author":"Human","key":"ref65","unstructured":"Human. Ethics and Consent to Participate Declaration."},{"volume-title":"Institutional Review Board at the University of Illinois Chicago","author":"All procedures were approved by the","key":"ref66","unstructured":"All procedures were approved by the. Institutional Review Board at the University of Illinois Chicago. All participants gave informed consent prior to participating."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6347618\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6347618\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:06:48Z","timestamp":1767024408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6347618\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":66,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6347618\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13722-025-00621-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,4,28]]},"subtype":"preprint"}}